drainag
irrit
ie
smoke
exposur
poorli
humidifi
air
gastrointestin
reflux
diseas
foreign
bodi
acut
thyroid
refer
pain
ie
dental
infecti
caus
includ
viral
bacteri
immunecompromis
patient
fungal
caus
consid
import
infect
ga
possibl
complic
infecti
pharyng
viral
caus
includ
influenza
coronaviru
rhinoviru
adenoviru
enteroviru
human
immunodefici
viru
hiv
epsteinbarr
viru
ebv
cytomegaloviru
herp
simplex
viru
major
risk
factor
ga
age
exposur
childhood
pharyng
caus
ga
outbreak
occur
winter
earli
spring
age
group
spread
close
contact
school
home
ga
uncommon
preschoolag
children
adult
group
c
g
betahemolyt
streptococcu
caus
pharyng
older
children
adult
infect
similar
less
sever
lead
signific
complic
ga
infect
consid
mycoplasma
chlamydia
infect
young
adult
present
pharyng
bronchiti
fusobacterium
necrophorum
fn
oblig
anaerob
gramneg
bacillu
report
caus
pharyng
adolesc
unit
kingdom
denmark
although
conclus
pathogen
pharyng
suggest
caus
agent
lemierr
syndrom
septic
thrombophleb
intern
jugular
vein
septic
emboli
lung
physic
examin
patient
focus
headneckchest
skin
initi
examin
provid
assess
sign
lifethreaten
diseas
especi
children
difficulti
local
pain
red
flag
impend
lifethreaten
deterior
includ
difficulti
handl
secret
drool
hotpotato
voic
toxic
appear
unilater
neck
swell
clinician
must
quickli
rule
parapharyng
space
infect
peritonsilar
abscess
submandibular
abscess
ludwig
angina
epiglott
condit
requir
emerg
care
patient
complain
sore
throat
nasal
congest
coryza
hoars
sinu
discomfort
ear
pain
cough
conjunct
diarrhea
discret
ulcer
stomat
herpangina
coxsacki
viru
manifest
fever
pain
vesicular
lesion
posterior
oropharynx
hand
foot
mouth
diseas
coxsacki
pain
vesicl
ulcer
mouth
palm
sole
patient
present
classic
triad
sever
sore
throat
diffus
lymphadenopathi
fever
c
f
case
caus
infect
human
herpesviru
commonli
known
ebv
remain
case
caus
cytomegaloviru
herp
viru
herp
viru
prodrom
chill
sweat
fever
malais
onethird
patient
present
exud
palat
petechia
may
mimic
ga
infect
approxim
patient
present
jaundic
rash
onethird
adult
adolesc
signific
ill
wherea
children
subclin
infect
patient
mononucleosi
ingest
blactam
antibiot
often
develop
prurit
maculopapular
rash
primari
hiv
infect
mimic
ebv
infect
patient
present
fever
nonexud
pharyng
weight
loss
diffus
adenopathi
patient
develop
rash
week
infect
ga
pharyng
classic
present
sudden
onset
sever
sore
throat
pain
swallow
fever
without
cough
rhinorrhea
clinic
sign
includ
tonsillar
erythema
without
exud
anterior
cervic
aden
soft
palat
petechia
red
swollen
uvula
scarlatiniform
rash
patent
ga
may
milder
symptom
clinic
sign
tonsillectomi
children
less
year
age
group
b
streptococc
infect
may
present
atyp
symptom
lowgrad
fever
tender
anterior
adenopathi
nasal
congestiondischarg
nonsuppur
complic
rare
benefit
treat
children
decreas
transmiss
infecti
diseas
societi
america
idsa
american
pediatr
academi
apa
recommend
test
children
unless
risk
factor
present
scarlet
fever
ga
pharyng
infect
bacteri
strain
produc
erythrogen
toxin
characterist
fine
goosepimpl
red
rash
blanch
pressur
rash
begin
neck
spread
trunk
extrem
spare
face
pronounc
creas
rash
fade
day
skin
may
subsequ
desquam
expert
clinician
reliabl
identifi
patient
infect
ga
therefor
microbiolog
confirm
necessari
diagnos
ga
pharyng
sever
predict
tool
determin
probabl
ga
infect
propos
idsa
recommend
use
clinic
score
system
reduc
unnecessari
test
treatment
centor
criteria
adult
modifi
mcissac
colleagu
includ
age
criterion
expand
applic
tool
age
tabl
criterion
consid
low
risk
requir
addit
evalu
antibiot
treatment
criteria
assess
ga
treat
posit
guidelin
manag
patient
criteria
differ
although
american
colleg
physician
acp
recommend
empir
treatment
individu
posit
criteria
idsa
american
heart
associ
aha
routin
empir
treatment
ga
patient
criteria
increas
unnecessari
use
antibiot
clinic
symptom
suggest
ga
infect
throat
cultur
rapid
antigen
detect
test
radt
dna
probe
test
indic
specimen
obtain
initi
antibiot
even
dose
caus
test
neg
tonsil
posterior
pharynx
aggress
swab
area
mouth
avoid
swab
children
throat
cultur
perform
radt
neg
order
identifi
patient
falseneg
result
adult
throat
cultur
necessari
neg
radt
low
incid
ga
low
risk
acut
rheumat
fever
rf
laboratori
replac
throat
cultur
conform
dna
probe
test
turnaround
time
hour
compar
hour
throat
cultur
valu
obtain
streptococc
antibodi
test
antistreptolysin
aso
antideoxyribonucleas
b
acut
ga
infect
test
need
diagnos
acut
rf
acut
mononucleosi
complet
blood
count
show
absolut
lymphocytosi
greater
atyp
lymphocyt
within
week
heterophil
antibodi
test
becom
posit
higher
falseneg
rate
children
ebvspecif
antibodi
may
necessari
diagnosi
presumpt
diagnosi
acut
retrovir
syndrom
made
hiv
antigen
detect
hiv
antibodi
may
neg
hiv
viral
load
assay
copiesml
confirm
diagnosi
consid
group
c
g
streptococc
infect
radtcultur
neg
patient
continu
sever
symptom
diagnosi
requir
throat
cultur
special
notic
laboratori
specif
strain
interest
mani
laboratori
ignor
cultur
fn
confirm
growth
fn
bacteria
anaerob
blood
cultur
symptom
relief
especi
pain
goal
treatment
patient
confirm
ga
infect
given
antibiot
saltwat
gargl
phenol
throat
spray
herbal
remedi
often
recommend
studi
recommend
discourag
practic
sip
warm
cold
beverag
advoc
honey
avoid
less
l
year
age
concern
regard
botul
ambroxol
lidocain
lozeng
significantli
better
placebo
provid
pain
relief
without
advers
effect
benzocain
lozeng
also
provid
pain
relief
howev
us
food
drug
administr
publish
concern
risk
methemoglobinemia
use
oral
rins
equal
part
lidocain
diphenhydramin
maalox
may
help
patient
stomat
gingiv
ulcer
import
patient
swish
expector
avoid
overdos
lidocian
idsa
advis
use
aspirin
nonsteroid
antiinflammatori
agent
nsaia
adult
nsaia
children
treatment
pain
sever
studi
show
nsaia
reliev
pharyng
pain
better
acetaminophen
use
glucocorticoid
treatment
pharyng
controversi
idsa
recommend
use
glucocorticoid
decreas
durat
pain
glucocorticoid
restrict
except
patient
sever
sore
throat
inabl
swallow
singl
dose
oral
dexamethason
mgkg
maximum
mg
recommend
adult
singl
dose
prednison
mg
day
accept
antibiot
ga
penicillin
remain
antibiot
choic
ga
pharyng
tabl
resist
develop
penicillin
strain
ga
develop
toler
minim
inhibitori
concentr
greater
clinic
signific
unknown
amoxicillin
replac
penicillin
treatment
better
tast
penicillin
oral
form
patient
allerg
penicillin
firstgener
cephalosporin
macrolid
may
substitut
high
rate
resist
macrolid
antibiot
given
day
erad
ga
pharynx
time
shortcours
treatment
recommend
except
cefpodoxim
cefdinir
azithromycin
european
guidelin
treatment
ga
symptomat
treatment
alon
consid
selflimit
diseas
antibiot
commonli
recommend
provid
moder
clinic
benefit
diseas
low
complic
rate
antibiot
prescrib
sever
case
grow
bodi
evid
treat
patient
ga
pharyng
prevent
rare
case
rf
clinic
prudent
penicillin
anaphylaxi
occur
approxim
patient
fatal
rate
shock
overal
morbid
day
antibiot
may
high
group
c
g
betahemolyt
streptococcu
use
dose
ga
treat
day
fn
treatment
pharyng
controversi
clinician
recommend
consider
treat
patient
year
age
centor
criteria
penicillin
cephalosporin
uncertain
whether
treatment
effect
prevent
lemierr
syndrom
patient
ga
pharyng
improv
day
better
time
patient
seen
diagnost
reconsider
develop
suppur
complic
test
cure
either
radt
throat
cultur
indic
patient
person
histori
rf
develop
ga
rf
streptococc
glomerulonephr
outbreak
recurr
spread
among
famili
member
patient
repeat
symptomat
episod
ga
either
carrier
ga
recurr
viral
infect
nonadher
antibiot
therapi
new
ga
infect
rare
treatment
failur
patient
experi
second
episod
ga
short
interv
practition
repeat
cours
therapi
antibiot
greater
blactamas
stabil
treat
intramuscular
penicillin
recommend
obtain
radt
throat
cultur
second
cours
antibiot
concern
ga
spread
among
close
contact
close
contact
test
ga
posit
treat
famili
pet
reservoir
spread
ga
idsa
recommend
tonsillectomi
sole
reduc
frequenc
ga
pharyng
tonsillectomi
provid
shortliv
benefit
small
fraction
patient
howev
mani
clinician
consid
tonsillectomi
child
sever
affect
ga
pharyng
ie
document
ga
infect
within
year
within
year
within
year
indic
tonsillectomi
includ
tonsillar
obstruct
recurr
peritonsillar
abscess
chronic
ga
carrier
close
contact
patient
rf
children
ga
carrier
clinician
suspect
ga
carrier
clinic
pictur
viral
pharyng
patient
posit
radt
throat
cultur
symptomat
asymptomat
serolog
respons
aso
antidnas
b
low
risk
complic
need
identifi
treat
need
attempt
erad
ga
pharynx
spread
diseas
other
complic
ga
pharyng
classifi
suppur
nonsuppur
nonsuppur
complic
includ
acut
rf
acut
poststreptococc
glomerulonephr
poststrep
gn
poststreptococc
reactiv
arthriti
rf
rare
develop
countri
unit
state
last
rf
epidem
occur
week
ga
pharyng
seen
skin
infect
rf
diagnos
use
revis
jone
criteria
acut
rf
start
antibiot
within
day
symptom
prevent
acut
rf
acut
poststrep
gn
occur
approxim
day
pharyng
infect
day
skin
infect
antibiot
alter
attack
rate
poststreptococc
reactiv
arthriti
similar
reactiv
arthriti
alter
antibiot
suppur
complic
includ
peritonsillar
abscess
retropharyng
abscess
sinus
otiti
media
mastoid
appropri
treatment
ga
pharyng
may
decreas
complic
pediatr
autoimmun
neuropsychiatr
disord
associ
group
streptococci
panda
controversi
diagnosi
children
whose
obsessivecompuls
disord
tic
disord
worsen
ga
infect
